Recombinant Human CREB3L2 Protein, N-His from ProteoGenix; catalogue ARO-P11261; research use only.
Know who made it. See the evidence. Buy through one marketplace.
The Recombinant Human CREB3L2 Protein is a highly versatile protein that plays a crucial role in various biological processes. It is a member of the cAMP response element binding (CREB) family of transcription factors and is encoded by the CREB3L2 gene. This protein has been extensively studied and has been found to have important functions in both normal and pathological conditions. In this article, we will discuss the structure, activity, and applications of Recombinant Human CREB3L2 Protein.
The human CREB3L2 gene is located on chromosome 7 and consists of 12 exons. The protein is composed of 509 amino acids with a molecular weight of approximately 58 kDa. It contains a basic leucine zipper (bZIP) domain, which is responsible for DNA binding and dimerization, and a transmembrane domain, which anchors the protein to the endoplasmic reticulum (ER) membrane. The bZIP domain is also involved in the interaction with other proteins and regulates the transcriptional activity of CREB3L2.
The main activity of Recombinant Human CREB3L2 Protein is its role as a transcription factor. It is activated in response to various stress signals, such as ER stress, hypoxia, and viral infection. Upon activation, CREB3L2 translocates from the ER to the Golgi apparatus, where it is cleaved by proteases, releasing the active form of the protein. The active form then translocates to the nucleus, where it binds to specific DNA sequences and regulates the expression of target genes.
Studies have shown that CREB3L2 is involved in the regulation of various biological processes, including cell proliferation, differentiation, and survival. It has also been implicated in the development and progression of several diseases, such as cancer, neurodegenerative disorders, and metabolic disorders. For example, CREB3L2 has been found to promote the growth and survival of cancer cells by regulating the expression of genes involved in cell cycle progression and apoptosis. On the other hand, it has been shown to have a protective role in neurodegenerative diseases by promoting the clearance of misfolded proteins in the ER.
Due to its diverse functions and involvement in various diseases, Recombinant Human CREB3L2 Protein has a wide range of applications in both basic and clinical research. One of the main applications is in the study of the ER stress response and its role in disease development. Researchers can use recombinant CREB3L2 protein to investigate the mechanisms of ER stress and its effects on cell function and survival. This can provide valuable insights into the pathogenesis of diseases and potential therapeutic targets.
Another important application of Recombinant Human CREB3L2 Protein is in drug discovery and development. As mentioned earlier, CREB3L2 is involved in the regulation of various biological processes, making it a potential target for drug intervention. By studying the activity and function of recombinant CREB3L2 protein, researchers can identify compounds that can modulate its activity and potentially develop new treatments for diseases.
Furthermore, recombinant CREB3L2 protein can also be used in diagnostic assays. As CREB3L2 is involved in the development and progression of certain diseases, its levels and activity can serve as biomarkers for disease diagnosis and prognosis. By using recombinant CREB3L2 protein in diagnostic tests, researchers can accurately detect and monitor disease progression.
In conclusion, Recombinant Human CREB3L2 Protein is a crucial protein with diverse functions in various biological processes. Its structure, activity, and applications have been extensively studied and continue to
ProteoGenix catalogue number ARO-P11261. For research use only.
Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 17.58 kDa; Fragment: Ala245-Leu380; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
